Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniela Barlocco

Showing results (1-10 of 37) with videos related to

Pageof 4
Sort By:
Current Opinion in Investigational Drugs (London, England : 2000)|June 18, 2003
Insulin detemir. Novo NordiskDaniela Barlocco
Current Opinion in Investigational Drugs (London, England : 2000)|December 3, 2003
Insulin glulisine. Aventis PharmaDaniela Barlocco
Current Opinion in Investigational Drugs (London, England : 2000)|November 13, 2004
LAF-237 (Novartis)Daniela Barlocco
Current Opinion in Investigational Drugs (London, England : 2000)|May 19, 2005
Muraglitazar (Bristol-Myers Squibb/Merck)Daniela Barlocco
Pharmaceuticals (Basel, Switzerland)|April 30, 2021
Special Issue "Novel Antibacterial Agents"Fiorella Meneghetti, Daniela Barlocco
Current Medicinal Chemistry|November 17, 2004
Inhibitors for proteins endowed with catalytic and non-catalytic activity which recognize pTyrLuca Costantino, Daniela Barlocco
Future Medicinal Chemistry|April 1, 2015
New perspectives on the development of antiobesity drugsLuca Costantino, Daniela Barlocco
Journal of Medicinal Chemistry|March 24, 2016
Ten Years of Medicinal Chemistry (2005-2014) in the Journal of Medicinal Chemistry: Country of Contributors, Topics, and Public-Private PartnershipsLuca Costantino, Daniela Barlocco
Molecules (Basel, Switzerland)|July 8, 2017
Special Issue: Frontiers in Antimicrobial Drug Discovery and DesignDaniela Barlocco, Fiorella Meneghetti
Future Medicinal Chemistry|March 24, 2011
Ghrelin receptor modulators and their therapeutic potentialLuca Costantino, Daniela Barlocco
Pageof 4

Showing results (1-10 of 37) with videos related to

Sort By:
Pageof 4
Current Opinion in Investigational Drugs (London, England : 2000)|June 18, 2003
Insulin detemir. Novo NordiskDaniela Barlocco
Current Opinion in Investigational Drugs (London, England : 2000)|December 3, 2003
Insulin glulisine. Aventis PharmaDaniela Barlocco
Current Opinion in Investigational Drugs (London, England : 2000)|November 13, 2004
LAF-237 (Novartis)Daniela Barlocco
Current Opinion in Investigational Drugs (London, England : 2000)|May 19, 2005
Muraglitazar (Bristol-Myers Squibb/Merck)Daniela Barlocco
Pharmaceuticals (Basel, Switzerland)|April 30, 2021
Special Issue "Novel Antibacterial Agents"Fiorella Meneghetti, Daniela Barlocco
Current Medicinal Chemistry|November 17, 2004
Inhibitors for proteins endowed with catalytic and non-catalytic activity which recognize pTyrLuca Costantino, Daniela Barlocco
Future Medicinal Chemistry|April 1, 2015
New perspectives on the development of antiobesity drugsLuca Costantino, Daniela Barlocco
Journal of Medicinal Chemistry|March 24, 2016
Ten Years of Medicinal Chemistry (2005-2014) in the Journal of Medicinal Chemistry: Country of Contributors, Topics, and Public-Private PartnershipsLuca Costantino, Daniela Barlocco
Molecules (Basel, Switzerland)|July 8, 2017
Special Issue: Frontiers in Antimicrobial Drug Discovery and DesignDaniela Barlocco, Fiorella Meneghetti
Future Medicinal Chemistry|March 24, 2011
Ghrelin receptor modulators and their therapeutic potentialLuca Costantino, Daniela Barlocco
Pageof 4